Orbita 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ORBITA-2 trial: Percutaneous coronary intervention improved chest pain and quality of life vs. placebo in stable angina patients.

United kingdomUnited statesCity ofRasha al lameeImperial college healthcareAmerican heart association scientific sessionsCanadian cardiovascular societyImperial college london rasha al lameeBritish heart foundationImperial college londonOdds ratioConfidence intervalAha 2023Orbita 2Pci for stable angina